171 related articles for article (PubMed ID: 15269099)
1. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome.
Polgár B; Nagy E; Mikó E; Varga P; Szekeres-Barthó J
Biol Reprod; 2004 Nov; 71(5):1699-705. PubMed ID: 15269099
[TBL] [Abstract][Full Text] [Related]
2. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
Hudić I; Fatusić Z
J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
[TBL] [Abstract][Full Text] [Related]
3. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
Kalinka J; Szekeres-Bartho J
Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
[TBL] [Abstract][Full Text] [Related]
4. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery.
Raghupathy R; Al-Mutawa E; Al-Azemi M; Makhseed M; Azizieh F; Szekeres-Bartho J
J Reprod Immunol; 2009 Jun; 80(1-2):91-9. PubMed ID: 19371956
[TBL] [Abstract][Full Text] [Related]
5. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
Szekeres-Bartho J; Par G; Dombay Gy; Smart YC; Volgyi Z
Cell Immunol; 1997 May; 177(2):194-9. PubMed ID: 9178647
[TBL] [Abstract][Full Text] [Related]
6. PIBF: the double edged sword. Pregnancy and tumor.
Szekeres-Bartho J; Polgar B
Am J Reprod Immunol; 2010 Aug; 64(2):77-86. PubMed ID: 20367622
[TBL] [Abstract][Full Text] [Related]
7. Lower Urinary and Serum Progesterone-Induced Blocking Factor in Women with Preterm Birth.
Hudić I; Szekeres-Bartho J; Stray-Pedersen B; Fatušić Z; Polgar B; Ećim-Zlojutro V
J Reprod Immunol; 2016 Sep; 117():66-9. PubMed ID: 27479613
[TBL] [Abstract][Full Text] [Related]
8. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes.
Szekeres-Bartho J; Faust Z; Varga P
Am J Reprod Immunol; 1995 Dec; 34(6):342-8. PubMed ID: 8607938
[TBL] [Abstract][Full Text] [Related]
9. Changes of progesterone-induced blocking factor in patients after kidney transplantation.
Fekecs T; Kalmár-Nagy K; Szakály P; Németh K; Moezzi M; Zapf I; Horváth OP; Bartho-Szekeres J; Ferencz A
Transplant Proc; 2011 Dec; 43(10):3694-6. PubMed ID: 22172828
[TBL] [Abstract][Full Text] [Related]
10. A progesterone-induced protein increases the synthesis of asymmetric antibodies.
Kelemen K; Bognar I; Paal M; Szekeres-Bartho J
Cell Immunol; 1996 Jan; 167(1):129-34. PubMed ID: 8548836
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of a novel monoclonal antibody against progesterone-induced blocking factor (PIBF).
Ivanova-Todorova E; Kyurkchiev DS; Nalbanski A; Timeva T; Shterev A; Kyurkchiev SD
J Reprod Immunol; 2008 Jul; 78(2):94-101. PubMed ID: 18243332
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum progesterone-induced blocking factor (PIBF) in the prediction of preterm birth.
Hudić I; Stray-Pedersen B; Szekeres-Bartho J; Fatušić Z; Dizdarević-Hudić L; Tomić V; Polgar B; Hadžiefendić B; Fatušić J
J Reprod Immunol; 2015 Jun; 109():36-40. PubMed ID: 25818991
[TBL] [Abstract][Full Text] [Related]
13. ELISA test for the detection of an immunological blocking factor in human pregnancy serum.
Szekeres-Bartho J; Varga P; Pejtsik B
J Reprod Immunol; 1989 Sep; 16(1):19-29. PubMed ID: 2600930
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum progesterone-induced blocking factor at 11-13 weeks' gestation in spontaneous early preterm delivery.
Beta J; Szekeres-Bartho J; Skyfta E; Akolekar R; Nicolaides KH
Fetal Diagn Ther; 2011; 29(3):197-200. PubMed ID: 21212635
[TBL] [Abstract][Full Text] [Related]
15. Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks.
Salomon LJ; Rozenberg P; Szekeres-Bartho J; Malagrida L; Giudicelli Y; Ville Y
J Matern Fetal Neonatal Med; 2005 May; 17(5):353-6. PubMed ID: 16147850
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production by lymphocytes in pregnancy.
Szereday L; Varga P; Szekeres-Bartho J
Am J Reprod Immunol; 1997 Dec; 38(6):418-22. PubMed ID: 9412725
[TBL] [Abstract][Full Text] [Related]
17. Progesterone-dependent immunomodulation.
Szekeres-Bartho J; Polgar B; Kozma N; Miko E; Par G; Szereday L; Barakonyi A; Palkovics T; Papp O; Varga P
Chem Immunol Allergy; 2005; 89():118-125. PubMed ID: 16129958
[TBL] [Abstract][Full Text] [Related]
18. Dydrogesterone supplementation in women with threatened preterm delivery--the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor.
Hudić I; Szekeres-Bartho J; Fatušić Z; Stray-Pedersen B; Dizdarević-Hudić L; Latifagić A; Hotić N; Kamerić L; Mandžić A
J Reprod Immunol; 2011 Dec; 92(1-2):103-7. PubMed ID: 22032897
[TBL] [Abstract][Full Text] [Related]
19. Progesterone-induced blocking factor and cytokine profile in women with threatened pre-term delivery.
Hudić I; Fatusić Z; Szekeres-Bartho J; Balić D; Polgar B; Ljuca D; Dizdarević-Hudić L
Am J Reprod Immunol; 2009 May; 61(5):330-7. PubMed ID: 19343831
[TBL] [Abstract][Full Text] [Related]
20. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production.
Szekeres-Bartho J; Faust Z; Varga P; Szereday L; Kelemen K
Am J Reprod Immunol; 1996 Apr; 35(4):348-51. PubMed ID: 8739452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
